Sentinel lymph node mapping in melanoma with Technetium-99m Dextran

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 3, 2001, Pages 265-267

  Neubauer, S ^a   Mena, I ^a   Iglesis, R ^a   Schwartz, R ^a   Acevedo, J C ^a   Leon, A ^a   Gomez, L ^a  

^a CLÍNICA LAS CONDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HUMAN; IMAGE ANALYSIS; LYMPH NODE BIOPSY; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; MERKEL CELL TUMOR; PRIORITY JOURNAL; RADIOACTIVITY; SCINTILLATION CAMERA; SENTINEL LYMPH NODE; SKIN DEFECT;

EID: 0034959151     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/10849780152389447     Document Type: Article

References (8)

1. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer and other potential cancers
2. Symposium on sentinel node imaging. Sentinel node and lymphoscintigraphy in breast cancer
3. Symposium on sentinel node imaging. Sentinel node lymphoscintigraphy in malignant melanoma
4. Use of sentinel node lymphoscintigraphy in malignant melanoma
5. Unexpected sentinel node location found by lymphoscintigraphy
6. Symposium on sentinel node imaging. Specification and performance of intra-operative gamma probes for sentinel node detection
7. Symposium on sentinel node imaging. Radiopharmaceuticals for sentinel node detection
8. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled Dextran